TR200806298A2 - Farmasötik formülasyon - Google Patents
Farmasötik formülasyonInfo
- Publication number
- TR200806298A2 TR200806298A2 TR2008/06298A TR200806298A TR200806298A2 TR 200806298 A2 TR200806298 A2 TR 200806298A2 TR 2008/06298 A TR2008/06298 A TR 2008/06298A TR 200806298 A TR200806298 A TR 200806298A TR 200806298 A2 TR200806298 A2 TR 200806298A2
- Authority
- TR
- Turkey
- Prior art keywords
- pharmaceutical formulation
- pharmaceutical compositions
- active ingredients
- compositions containing
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Abstract
Mevcut buluş, stabilite sorunu olan iki aktif maddeyi içeren farmasötik bileşimlere, bu bileşimlerin hazırlanma yöntemlerine ve tıbbi kullanımlarına ilişkindir.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2008/06298A TR200806298A2 (tr) | 2008-08-22 | 2008-08-22 | Farmasötik formülasyon |
EP09788682.4A EP2331079B1 (en) | 2008-08-22 | 2009-08-24 | Pharmaceutical formulation |
PCT/TR2009/000107 WO2010021607A2 (en) | 2008-08-22 | 2009-08-24 | Pharmaceutical formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2008/06298A TR200806298A2 (tr) | 2008-08-22 | 2008-08-22 | Farmasötik formülasyon |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200806298A2 true TR200806298A2 (tr) | 2010-03-22 |
Family
ID=41707588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2008/06298A TR200806298A2 (tr) | 2008-08-22 | 2008-08-22 | Farmasötik formülasyon |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2331079B1 (tr) |
TR (1) | TR200806298A2 (tr) |
WO (1) | WO2010021607A2 (tr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201009394A2 (tr) * | 2010-11-11 | 2012-06-21 | Bi̇lgi̇ç Mahmut | Geliştirilmiş montelukast formülasyonları. |
CN102973532A (zh) * | 2012-12-28 | 2013-03-20 | 南京瑞尔医药有限公司 | 一种稳定的孟鲁司特钠片剂及制备方法 |
CN104546851B (zh) * | 2013-10-29 | 2018-01-02 | 北京韩美药品有限公司 | 一种颗粒组合物及其制备方法、制剂 |
CA2939082C (en) | 2014-02-13 | 2022-06-07 | Incyte Corporation | Cyclopropylamines as lsd1 inhibitors |
ME03580B (me) | 2014-02-13 | 2020-07-20 | Incyte Corp | Ciklopropilamini kao lsd1 inhibitori |
WO2016007722A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Triazolopyridines and triazolopyrazines as lsd1 inhibitors |
TWI714567B (zh) | 2015-04-03 | 2021-01-01 | 美商英塞特公司 | 作為lsd1抑制劑之雜環化合物 |
CR20180152A (es) | 2015-08-12 | 2018-08-09 | Incyte Corp | Sales de un inhibidor de lsd1 |
CN105616368B (zh) * | 2016-01-22 | 2017-02-22 | 山东新时代药业有限公司 | 一种孟鲁司特钠片剂及其制备方法 |
CA3099055A1 (en) | 2018-05-02 | 2019-11-07 | Ferring B.V. | Improved pharmaceutical formulations |
WO2019245015A1 (ja) * | 2018-06-22 | 2019-12-26 | 参天製薬株式会社 | デスロラタジン又はその塩を含有する医薬組成物 |
WO2020047198A1 (en) | 2018-08-31 | 2020-03-05 | Incyte Corporation | Salts of an lsd1 inhibitor and processes for preparing the same |
CN111419820B (zh) * | 2020-04-23 | 2022-03-25 | 合肥医工医药股份有限公司 | 一种枸地氯雷他定胶囊剂及其制备方法和应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU194864B (en) | 1984-02-15 | 1988-03-28 | Schering Corp | Process for production of 8-chlor-6,11-dihydro-11-(4-piperidilidene)-5h-benzo (5,6)-cyclo-hepta (1,2-b) pyridine and its salts |
US4731447A (en) | 1985-05-13 | 1988-03-15 | Schering Corporation | Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof |
EP0208855B1 (en) | 1985-05-13 | 1991-03-06 | Schering Corporation | process for preparing piperidylidene dihydrodibenzo(a,d)cycloheptenes and aza derivatives thereof, compounds obtained by such process and the use of such compounds for preparing useful pharmaceutical compositions |
US4873335A (en) | 1986-03-12 | 1989-10-10 | Schering Corporation | 3-phenethyl-2-benzene-amides or aza-derivatives thereof |
US5856322A (en) | 1990-10-12 | 1999-01-05 | Merck Frosst Canada, Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
DK0480717T3 (da) | 1990-10-12 | 1999-02-08 | Merck Frosst Canada Inc | Umættede hydroxyalkylquinolinsyrer som leukotrienantagonister |
US5565473A (en) | 1990-10-12 | 1996-10-15 | Merck Frosst Canada, Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
CZ248798A3 (cs) * | 1996-02-08 | 1999-01-13 | Merck And Co., Inc. | Farmaceutický prostředek |
TW522014B (en) | 1997-02-07 | 2003-03-01 | Sepracor Inc | Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine |
DK1041990T3 (da) | 1997-12-23 | 2006-10-02 | Schering Corp | Præparat til behandling af respiratoriske sygdomme og hudsygdomme med mindst en leukotrien-antagonist og mindst et antihistamin |
DE69916042T2 (de) | 1998-07-10 | 2004-11-11 | Schering Corp. | Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-benzo[5,6]cyclohepta[1,2-b]pyridin |
US6100274A (en) | 1999-07-07 | 2000-08-08 | Schering Corporation | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
WO2003101434A2 (en) * | 2001-12-21 | 2003-12-11 | Sampad Bhattacharya | Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor |
EP1696881A2 (en) | 2003-12-23 | 2006-09-06 | Sun Pharmaceutical Industries Limited | Stable oral composition |
AU2005263958B2 (en) | 2004-07-16 | 2011-04-14 | Cipla Limited | Anti-histaminic composition |
EP1728513A3 (en) | 2005-05-20 | 2007-10-31 | Dr. Reddy's Laboratories, Inc. | Stable desloratadine compositions |
PT1818057E (pt) | 2006-02-09 | 2010-06-18 | Teva Pharma | Formulações farmacêuticas estáveis de montelucaste de sódio |
CA2541045A1 (en) * | 2006-03-24 | 2007-09-24 | Pharmascience Inc. | A descarbonylethoxyloratadine containing pharmaceutical composition |
WO2008079312A2 (en) * | 2006-12-22 | 2008-07-03 | Schering Corporation | Compositions for treatment of nasal congestion |
-
2008
- 2008-08-22 TR TR2008/06298A patent/TR200806298A2/tr unknown
-
2009
- 2009-08-24 WO PCT/TR2009/000107 patent/WO2010021607A2/en active Application Filing
- 2009-08-24 EP EP09788682.4A patent/EP2331079B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
WO2010021607A2 (en) | 2010-02-25 |
EP2331079B1 (en) | 2013-12-18 |
WO2010021607A4 (en) | 2010-07-22 |
WO2010021607A3 (en) | 2010-06-03 |
EP2331079A2 (en) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200806298A2 (tr) | Farmasötik formülasyon | |
CY1122853T1 (el) | Σταθερα σκευασματα λινακλοτιδης | |
CY1118680T1 (el) | Φαρμακευτικη συνθεση | |
EA201401351A1 (ru) | Производные бензимидазол-пролина | |
PH12014502778A1 (en) | Antibody formulation | |
WO2012088266A3 (en) | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 | |
EA201201050A1 (ru) | Пиразолы в качестве антагонистов crth2 | |
DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
EA201270741A1 (ru) | Пероральные композиции и липофильные соли метилналтрексона | |
EA201390799A1 (ru) | Триазолопиридины | |
MX342947B (es) | Tratamiento de diabetes tipo 2. | |
UY32520A (es) | Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides | |
EA201300857A1 (ru) | Пиразолы в качестве антагонистов crth2 | |
EA201290229A1 (ru) | Производные спиролактама и их применение | |
MX2019012375A (es) | Formulaciones del inhibidor del antigeno-1 asociado a la funcion de linfocitos (lfa-1). | |
TR200909785A1 (tr) | Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar. | |
BR112014016804A8 (pt) | composições, métodos de uso e métodos de tratamento | |
BR112012016736A2 (pt) | composição , formulação farmacêutica e uso da composição" | |
TR201007250A2 (tr) | Selobioz içeren formülasyon. | |
JP2009292763A5 (tr) | ||
TR201005327A2 (tr) | Sinerjik farmasötik formülasyonlar. | |
TR201109160A2 (tr) | Eplerenon içeren yeni farmasötik kompozisyonlar. | |
TR200806302A2 (tr) | Çözünürlük ve stabilite artırıcı farmasötik formülasyon. | |
TR200806305A2 (tr) | Çözünürlük ve stabilite artırıcı farmasötik bileşim | |
TR200806301A2 (tr) | Çözünürlük ve stabilite artırıcı farmasötik formülasyon. |